ArticleBMJ open2023

Immunogenicity and safety of mixed COVID-19 vaccine regimens in patients with immune-mediated inflammatory diseases: a single-centre prospective cohort study.

Carol A Hitchon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.